{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:48:32Z","timestamp":1794552512239,"version":"4.9.1"},"reference-count":73,"publisher":"American Chemical Society (ACS)","issue":"12","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["50-54100-98-103"],"award-info":[{"award-number":["50-54100-98-103"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["ERC CoG Grant Agreement no. 725523"],"award-info":[{"award-number":["ERC CoG Grant Agreement no. 725523"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Infect. Dis."],"published-print":{"date-parts":[[2021,12,10]]},"DOI":"10.1021\/acsinfecdis.1c00466","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T15:13:57Z","timestamp":1636730037000},"page":"3314-3335","source":"Crossref","is-referenced-by-count":25,"title":["Structure\u2013Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens"],"prefix":"10.1021","volume":"7","author":[{"given":"Charlotte M. J.","family":"Wesseling","sequence":"first","affiliation":[{"name":"Biological Chemistry Group, Institute of Biology Leiden, Leiden University, 2333 BE Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.","family":"Slingerland","sequence":"additional","affiliation":[{"name":"Biological Chemistry Group, Institute of Biology Leiden, Leiden University, 2333 BE Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanice","family":"Veraar","sequence":"additional","affiliation":[{"name":"Biological Chemistry Group, Institute of Biology Leiden, Leiden University, 2333 BE Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Lok","sequence":"additional","affiliation":[{"name":"Biological Chemistry Group, Institute of Biology Leiden, Leiden University, 2333 BE Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-3006","authenticated-orcid":true,"given":"Nathaniel I.","family":"Martin","sequence":"additional","affiliation":[{"name":"Biological Chemistry Group, Institute of Biology Leiden, Leiden University, 2333 BE Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2018-001820"},{"key":"ref2\/cit2","unstructured":"UN\nInteragency Coordination\nGroup on Antimicrobial Resistance. No time to wait: securing the future from drug-resistant infections.  Report to the Secretary-General of the United Nations,\nGeneva; WHO, 2019. https:\/\/www.who.int\/publications\/i\/item\/no-time-to-wait-securing-the-future-from-drug-resistant-infections (date accessed Oct 24, 2021)."},{"key":"ref3\/cit3","volume-title":"Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterialinfections Including Tuberculosis","author":"WHO","year":"2017"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01615-20"},{"key":"ref5\/cit5","first-page":"93","volume-title":"Drug Resistance Updates","author":"Nikaido H.","year":"1998"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1038\/303526a0"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.28"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03574"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2015.12.011"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm.2017.06.18"},{"key":"ref11\/cit11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-7020-7167-6.00051-8","volume-title":"Medical Pharmacology and Therapeutics","author":"Waller D. G.","year":"2018","edition":"5"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.5.625"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198733030-00002"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.9.1795"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.04.075"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/bi00146a011"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm1180"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1803975115"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01369"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.1.9"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1007\/s11171-005-0047-z"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1021\/ja00209a040"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1021\/jm00166a026"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.5562\/cca2141"},{"key":"ref26\/cit26","unstructured":"Ewins, A. J.; Barber, H. J.; Newbery, G.; Ashley, J. N.; Self, A. D. H. Verfahren zur Herstellung von Diamidinderivaten. DE 844897 C, 1952."},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/CR60210A003"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.10.026"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1039\/c6md00573j"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1021\/jm0300072"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1021\/acs.orglett.6b02359"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2011.12.010"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1002\/JPS.20627"},{"key":"ref34\/cit34","unstructured":"Wang, B.; Boykin, D.; Choudhary, M.; Kumar, A.; Yu, B.; Zhu, M. Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics. WO 2019241566 A1, 2019."},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/jm00227a011"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.06.034"},{"key":"ref37\/cit37","first-page":"38","volume":"27","author":"Chauhan P. M. S.","year":"1988","journal-title":"Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem."},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2009.03.014"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1021\/jm801547t"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1039\/jr9420000103"},{"key":"ref41\/cit41","unstructured":"Hamano, S.; Kanazawa, T.; Kitamura, S.I. Bis-(meta-amidinophenoxy)-compounds and pharmacologically acceptable acid addition salts thereof. U.S. Patent 4,034,010 A, 1977."},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1021\/ml400213v"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00484"},{"key":"ref44\/cit44","unstructured":"Kong, N.; Liu, E. A.; Vu, B. T. Cis-imidazolines. U.S. Patent 6,617,346 B1, 2003."},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1021\/jm4000984"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.80.359"},{"key":"ref47\/cit47","unstructured":"Martino, G.; Muzio, L.; Riva, N.; Gornati, D.; Seneci, P.; Eleuteri, S. Aminoguanidine hydrazones as retromer stabilizers useful for treating neurological diseases. WO 2020201326 A1, 2020."},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1039\/C4OB02238F"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.3987\/COM-08-S(F)85"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60219-5"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60322-X"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31449-3"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30801-X"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1001\/ARCHINTE.1956.00250250007001"},{"key":"ref55\/cit55","unstructured":"Drugs@FDA: FDA-Approved Drugs https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=050339 (accessed July 08, 2021)."},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26071954"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1093\/CLINIDS\/5.SUPPLEMENT_3.S412"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02153"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1080\/00021369.1987.10868532"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2020.108051"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.3390\/md13063325"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.12.443779"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHEMBIOL.2016.11.011"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2018.1492902"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.4.826"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.2000.00971.x"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02875-z"},{"key":"ref69\/cit69","unstructured":"Li, X.; Sun, C. L. Piperidine and piperazine derivatives. WO 2007089462 A2, 2007."},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1055\/S-0033-1338980"},{"key":"ref71\/cit71","unstructured":"Berglund, A. J.; Bodner, M. J. Aryl diamidines and prodrugs thereof for treating myotonic dystrophy. U.S. Patent 20,130,281,462 A1, 2013."},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1039\/C9OB00107G"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1038\/srep15963"}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.1c00466","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.1c00466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T21:36:04Z","timestamp":1682458564000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acsinfecdis.1c00466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,10]]}},"alternative-id":["10.1021\/acsinfecdis.1c00466"],"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.1c00466","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acsinfecdis.1c00466.s001","asserted-by":"subject"}]},"ISSN":["2373-8227","2373-8227"],"issn-type":[{"value":"2373-8227","type":"print"},{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}